-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Pyxis Oncology, Maintains $5 Price Target

Benzinga·03/19/2025 10:37:50
Listen to the news
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Pyxis Oncology (NASDAQ:PYXS) with a Buy and maintains $5 price target.